Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Glucagon-like peptide 1 (GLP-1) receptor agonist: The gastrointestinal tract releases GLP-1, a major incretin, in response to glucose consumption
Oral GLP-1 drugs are typically recommended to people with type 2 diabetes who: Prefer oral medications Have a needle phobia Require combination therapy alongside other antidiabetic medications Short-acting injectables These drugs are presented in a single-use injectable pen and must be administered once or twice a day
Growth factors such as (e.g., VEGF, platelet-derived growth factor [PDGF] bind to a receptor tyrosine kinase (RTK) on the cell membrane, causing autophosphorylation of the receptor, thus creating docking sites for intracellular signaling proteins
Body image disturbance A person with anorexia nervosa experiences a disturbance in the way in which their body weight or shape is experienced, significant influence of body weight or shape on self-evaluation, and/or persistent lack of recognition of the seriousness of their low body weight
While the term is a little tongue-in-cheek, the underlying science is sound
Gao M, Zhang N, Liang W
